Cargando…
Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma
Patients with peripheral T-cell lymphomas generally have poor clinical outcomes with conventional chemotherapy. Recent advances have demonstrated that a large subgroup of PTCL are derived from follicular helper (Tfh) T-cells. These cases show a characteristic pattern of gene expression, which includ...
Autores principales: | Mamand, Sami, Allchin, Rebecca L., Ahearne, Matthew J., Wagner, Simon D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154993/ https://www.ncbi.nlm.nih.gov/pubmed/30242208 http://dx.doi.org/10.1038/s41598-018-32634-5 |
Ejemplares similares
-
Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma
por: Allchin, Rebecca L., et al.
Publicado: (2019) -
PD1(hi) cells associate with clusters of proliferating B-cells in marginal zone lymphoma
por: Wickenden, Katherine, et al.
Publicado: (2018) -
IKKε and TBK1 in diffuse large B‐cell lymphoma: A possible mechanism of action of an IKKε/TBK1 inhibitor to repress NF‐κB and IL‐10 signalling
por: Carr, Matthew, et al.
Publicado: (2020) -
Interleukin-2-Inducible T-Cell Kinase (ITK) Deficiency - Clinical and Molecular Aspects
por: Ghosh, Sujal, et al.
Publicado: (2014) -
Interleukin‐2‐inducible T‐cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells
por: Mammadli, Mahinbanu, et al.
Publicado: (2021)